MIT sued over infected mice; miRagen launches PhI scleroderma study;

@FierceBiotech: China's new pharma crackdown may help top companies. Story | Follow @FierceBiotech

@JohnCFierce: Gilead, Sanofi singled out as worst offenders in failing to disclose trial data. More | Follow @JohnCFierce

@DamianFierce: $HZNP "is threatening $ESRX's profiteering and exposing ... a lack of care for patients and respect for physicians." News | Follow @DamianFierce

> An insurer for the Broad Institute is suing MIT, claiming that it provided mice that infected its labs with pinworms. Story

> Boulder, CO-based miRagen Therapeutics launched a Phase I clinical study of MRG-201, a synthetic microRNA mimic to microRNA-29b. The study starts with healthy volunteers and then may be extended to patients suffering from cutaneous scleroderma. Release

Medical Device News

@FierceMedDev: AliveCor adds former Google exec as CEO to further consumer ECG push. Story | Follow @FierceMedDev

@VarunSaxena2: Boston Sci's Watchman hit by restrictive CMS coverage decision, recall over blood leakage. Article | Follow @VarunSaxena2

@EmilyWFierce: Women are suing Endo Health Solutions and Patheon for child support after contraceptive packaging mishap. More | Follow @EmilyWFierce

> Resurgent 23andMe CEO says the genetic testing company is not up for sale. Article

> Philips to launch pneumonia Dx wearable to prevent child deaths in poorer countries. News

Pharma News

@FiercePharma: #ICYMI yesterday: U.S. judge orders Valeant, Ackman to face insider trading suit. Story | Follow @FiercePharma

@EricPFierce: ICYMI: #Novo makes sure Denmark gets some of the action as it starts massive build up. More | Follow @EricPFierce

@CarlyHFierce: U.S. judge orders Valeant, Ackman to face insider trading suit. Article | Follow @CarlyHFierce

> Novartis, Roche CEOs see performance-based future, but U.S. isn't ready yet. More

> Valeant employees closely involved with Philidor operations: Reuters. News

CRO News

> Quintiles lends its data-crunching know-how to Apple's ResearchKit. More

> PPD deepens its Japanese focus with new joint venture leadership. Story

> WuXi and Lilly pair up to develop a cardio drug in China. Article

> CRO BioDuro merges with Formex after a private equity takeout. More

> Quintiles founder stepping down as chairman after 33 years. News

Pharma Manufacturing News

> Endo, Patheon sued over unplanned pregnancies tied to contraceptive mishap. Item

> CMO Formex and CRO BioDuro merge operations. More

> Cellular Biomedicine adds facility in China that will help with CAR-T processing. Story

> AmerisourceBergen says quality will be PharMEDium's distinguisher, but acknowledges 'quick diligence' ahead of deal. Report

> Pharma cargo thefts jump with $558,000 average losses reported. News

Pharma Asia News

> India's drug regulator handcuffed by low funding, lack of trained personnel. Story

> Japan's Astellas Pharma gets $727M for ailing dermatology unit as it swings to new areas. More

> WuXi and Eli Lilly in pact on cardio candidate development in China. Article

> Japanese ministry knocks Novartis unit, again, on side effects nondisclosure. News

> Daiichi loses Supreme Court decision on Apotex generic. More

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

NYC’s outstanding talent and funding, the city is rich with life science real estate offerings across the five boroughs.

Sutro Biopharma’s lead antibody-drug conjugate shrank tumors in 13% of patients with ovarian cancer who had tried a median of six other treatments.

Immuno-oncology biotech Silverback Therapeutics has more than doubled its original IPO hopes.